MedPath

The Use of Antibiotic Sinonasal Rinse After Sinus Surgery

Phase 4
Completed
Conditions
Chronic Rhinosinusitis
Interventions
Drug: Placebo
Registration Number
NCT02218307
Lead Sponsor
University of Miami
Brief Summary

Double blind placebo controlled trial to evaluate whether the routine use of nasal irrigation with mupirocin is more effective than saline irrigations alone in reducing symptoms of chronic rhinosinusitis in the early postoperative period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Chronic Rhinosinusitis
  • Undergoing endoscopic sinus surgery
Exclusion Criteria
  • Age under 18
  • Documented adverse reaction to mupirocin

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MupirocinMupirocintopical antibiotic
PlaceboPlaceboPlacebo control for mupirocin
Primary Outcome Measures
NameTimeMethod
Quality of Life in Chronic Rhinosinusitis Patients3 months

Measuring the quality of life in chronic rhinosinusitis through completion of a questionnaire named SNOT 20 ( 20 questions for Sino-Nasal Outcome Test)

Snot20:

Scale 1 to 5 for 20 symptoms numbered below where 5 is the worst symptom. Total SNOT is scale from 0-100 where 100 is the worst.

The following are the elements:

1. need to blow 2. sneezing 3. runny nose 4. cough 5. postnasal drip 6. Thick nasal discharge 7. Ear fullness 8. Dizziness 9. Ear pain 10. facial pain/pressure 11. difficulty falling asleep 12. wake up at night 13. lack of a good night's sleep 14. wake up tired 15. Fatigue 16. Reduced productivity 17. Reduced concentration 18. frustrated/ restless/irritable 19. sad 20. Embarrassed

Secondary Outcome Measures
NameTimeMethod
Quality of Life in Chronic Rhinosinusitis Patients3 months

Measuring the quality of life in chronic rhinosinusitis through completion of a questionnaire named Visual Analog Scale for Nasal Obstruction/Congestion. VAS for nasal obstruction is scale from 0 to 100 where 100 mean worse.

Trial Locations

Locations (1)

University of Miami Miller School of Medicine, ENT Dept

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath